independent of other cardiovascular risk factors. Each increase of 1 standard deviation (0.13 mm) in CIMT increased the stroke risk by 43% (RR: 1.43, 1.002-2.02). Several factors were found to have a notable relation with CAA, including age, male sex, smoking, diabetes, systolic BP, HbA1c (glycosylated hemoglobin) and cholesterol. Conclusions: CIMT and atherosclerotic lesions are independent clinical markers for ischemic stroke among normotensive individuals.
Introduction
It is generally accepted that high blood pressure (BP) is the major risk factor for stroke [1] [2] [3] . A large majority of stroke cases have been exposed to this causal risk factor. In unselected populations, however, approximately 10-20% of stroke events occur in subjects having normal BP ( ! 140/90 mm Hg) [4] . Few researchers have paid attention to the risk of stroke in normotensive individuals [5, 6] .
In a large population-based study, the 'Malmö Diet and Cancer' (MDC) cohort, the risk of incident stroke has been investigated in subjects with normal BP [6] . A number of potential risk factors were found to be associated with incident stroke, including age, smoking, excess body weight, high systolic/normal diastolic BP, history of ischemic heart disease and gastric ulcers [6] . However, it is still unclear whether asymptomatic carotid atherosclerosis is associated with stroke in normotensive individuals.
Atherosclerosis has a long clinically silent phase lasting many years before the manifestation of overt disease. Carotid artery intima-media thickness (CIMT) is considered to be an early marker of arthrosclerosis. Increased CIMT have been shown to increase the risk of incident stroke, after statistical adjustment for hypertension [7] [8] [9] [10] [11] . However, hypertension is also a major determinant of CIMT [12] , and it can be assumed that high CIMT often reflect previous exposure to hypertension [13] [14] [15] . In this situation, statistical adjustment could be insufficient to fully account for the effects of hypertension on the relationship between CIMT and stroke. Analyses of normotensive individuals are also needed in order to fully explore the role of CIMT in the incidence of stroke.
The objective of this prospective study cohort was to investigate the impact of carotid artery atherosclerosis, defined by increased CIMT and/or carotid plaque, on the risk of first-ever ischemic stroke among the subjects who had normal blood pressure.
Materials and Methods

Study Population
From 1991 to 1996, all men and women born between 1923 and 1950 and living in the Malmö area in the southern part of Sweden were recruited into the MDC study. A detailed description of the MDC study has been given previously [16] . The cohort consists of 28,449 subjects from the eligible population of about 74,000 individuals. Detailed information about the participants has been provided elsewhere [17] .
A random 50% of participants who entered the MDC study between October 1991 and February 1994 were invited to take part in a study of the epidemiology of carotid artery diseases [18] . In total, 6,103 subjects (2,572 men and 3,531 women) were examined by B-mode ultrasound of the right carotid artery, and 5,540 participants returned to donate blood samples for measurements of blood lipids and glucose status. Subjects (n = 2,304) were included in the present study if they had a BP level ! 140/90 mm Hg and were not on BP-lowering treatment. Subjects with a history of stroke (n = 17) or had incomplete ultrasound data (n = 59) were excluded from the present analysis. Thus, the total study population consisted of 2,228 subjects.
The ethical committee at Lund University approved the MDC study (LU 51-90). All subjects gave informed consent.
Evaluation of Atherosclerotic Risk Factors
Baseline Characteristics A self-administered questionnaire was used to obtain information on lifestyle (i.e. smoking habits, daily alcohol intake and physical activity), clinical information (history of stroke, myocardial infarction and diabetes) and family history of cardiovascular disease (father, mother and/or sibling) [6] . Body weight, waist and hip girth and blood pressure were measured as previously described [6] . The presence of diabetes mellitus was accepted if subjects reported the diagnosis in questionnaire, or were treated with antidiabetic medication or had a fasting whole blood glucose level 6 6.1 mmol/l.
Carotid Artery Measurements
Participates underwent B-mode ultrasonography (Acuson 128 CT system, Mountain View, Calif., USA) of the right carotid artery. CIMT of the common carotid artery and the presence of carotid plaque were measured according to a standardized protocol by trained certified sonographers, as previously published [18] . In short, the bifurcation area of the right common carotid artery was scanned within a predefined 'window' comprising 3 cm of the right common carotid artery, the bifurcation, and 1 cm of both the internal and external carotid artery for the presence of plaque. CIMT was determined in the far wall of the right distal common carotid artery according to the leading edge principle, using a specially designed computer-assisted analyzing system [19] . CIMT was then determined off-line as the mean wall thickness 1 cm proximal to the bifurcation. Each image was analyzed without knowledge of the subject's identification code, to minimize the possibility of observer bias. Methods of quality control have been published previously and been considered satisfactory [18] .
In this study, 2 measures were adopted to estimate carotid artery atherosclerosis:
(1) CIMT: A mean CIMT 6 0.81 mm was considered abnormal. The cutoff point was based on the results issued from earlier publications within the MDC cohort [9, 20] . In these studies, higher risks of myocardial infarction and stroke were found in subjects with CIMT 6 0.81 mm.
(2) Atherosclerotic plaques: The presence of plaques within the prespecified window of the right carotid artery was defined as a focal thickening of CIMT 1 1.2 mm (visually judged) [9] . The numbers of plaques were classified as 1 or 6 2 plaques.
Laboratory Tests
After fasting overnight, blood samples were drawn to assess the profile of lipids [i.e. total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides], HbA1c (glycosylated hemoglobin) and glucose [21] . Hypercholesterolemia was defined as fasting total cholesterol 6 6.5 mmol/l. The assessment procedures were in accordance with the standard procedures at the Department of Clinical Chemistry, Malmö University Hospital.
Retrieval of End Point
Record linkage with the National Inpatient Register, the Swedish Causes of Death Register and the Stroke Register of Malmö provided information on morbidity and mortality from stroke in the MDC study [22] . Information on case retrieval, validity and ascertainment of cases in the MDC has been described in detail previously [9, 20] . In short, every participant was followed from the baseline examination until incidence of stroke, death or 31 December 2003. Stroke was defined as rapidly developing clinical signs of local or global loss of cerebral function that lasted for 1 24 h or led to death within 24 h. Classification as subarachnoid (ICD-9, code 430) or intracerebral hemorrhage (ICD-9, code 431) required verification with computed tomography (CT) and/or autopsy. In this study, the subtype of cerebral infarction (ischemic, ICD-9, code 434) was the end point, which was diagnosed when CT or autopsy could verify the infarction and/or exclude hemorrhage and nonvascular disease. If neither imaging nor autopsy was performed, the stroke was classified as unspecified (ICD-9, code 436). In subjects with more than 1 stroke event, only the first event was used for the analyses.
Statistical Analyses
A logistic regression model was adopted to assess the risk of carotid artery atherosclerosis (CAA; defined as CIMT 6 0.81 mm or/and presence of plaque) in relation to baseline characteristics and laboratory tests. Cox regression analyses with crude and covariate adjustments were used to assess the incidence of ischemic stroke in relation to CIMT, presence of plaque and CAA.
By using the Kaplan-Meier method [23] , the ischemic strokefree survival rate was estimated in line with the category of CAA. The classification of CAA was defined as follows: CAA-0 = CIMT ! 0.81 mm and absence of plaque; CAA-1 = CIMT 6 0.81 mm and absence of plaque, and CAA-2 = CIMT 6 0.81 mm and presence of plaque.
All comparisons were two-sided and a 5% level of significance was used. The statistical analyses were conducted by the computer software SPSS (version 11.5).
Results
In all, 2,228 subjects (791 men and 1,437 women) had a BP ! 140/90 mm Hg and were not on BP-lowering treatment. The mean age at baseline examination was 55.7 8 5.8 years.
Distribution of CAA CIMT was 0.73 8 0.13 mm (0.75 8 0.14 mm in men and 0.71 8 0.12 mm in women) and 23% had a CIMT level 6 0.81 mm. The presence of carotid plaques was a common finding, affecting 25.7% of the subjects (28.9% in men and 23.8% in women; table 1 ). The prevalence of CAA was 39.5% (n = 879).
Incidence of Ischemic Stroke in Relation to CAA
During a mean follow-up of 10.7 8 1.6 years (23,965 person-years), 36 subjects suffered a first-ever stroke (crude incidence: 1.51/1,000 person-years). Of them, 34 (94.4%) had cerebral infarction (ischemic), 1 had a subarachnoid hemorrhage and 1 had an unspecified stroke. In the present study, the cases with subarachnoid hemorrhage and unspecified subtypes were excluded from the analyses.
Among ischemic stroke cases, CAA at the baseline examination was found in more than two-thirds of the patients. Each 1-SD (0.13 mm) increase in CIMT increased the risk of stroke by 43% [relative risk (RR): 1.43, 1.002-2.02; table 2 ]. It was observed that the crude rates of ischemic stroke and the RR tended to increase in a linear fashion with increasing numbers of carotid plaques. In addition, the subjects who had CAA had a 3-fold higher risk (RR 3.60, 1.77-7.31) of ischemic stroke in comparison to the subjects without CAA ( table 2 ) . This risk increase remained nearly unchanged when age, sex, smoking, systolic BP, fasting glucose and LDL/HDL cholesterol ratios were taken into account (RR: 3.33, 1.37-8.14). Furthermore, it was also shown that the difference in ischemic stroke-free survival rates in relation to the severity of CAA increased continuously over time (age-and sex-adjusted p value for trend = 0.02; fig. 1 ). The absolute risk associated with presence of CAA was more than 3 times higher in comparison to absence of CAA (2.6 vs. 0.8%; 23 and 11 events among 877 and 1,349 subjects, respectively).
Because of the limited number of events, a backward stepwise model was also performed. This model included CIMT (as a continuous variable), age, sex, smoking, systolic BP, fasting glucose and LDL/HDL cholesterol ratio. Beside age, CIMT remained as a significant risk factor for an incident ischemic stroke. The same finding was observed when carotid plaques and CAA were used.
Risk Factors Associated with CAA
By using a logistic regression model with age and sex adjustments, the impact of baseline characteristics and laboratory parameters on the risk of developing CAA were examined ( table 3 ) . Several factors were found significantly associated with presence of CAA, e.g. age, male gender, current smoking, presence of diabetes and systolic BP, HbA1c, fasting glucose, total and LDL cholesterol. In addition, the presence of CAA was inversely related to HDL cholesterol.
Every third normotensive subject was found to have hypercholesterolemia. The age-and sex-adjusted odds ratio for CAA among subjects with hypercholesterolemia was 1.35 (1.10-1.65).
Discussion
Noninvasive imaging of the carotid artery, determined by B-mode ultrasonography, is increasingly used as a surrogate marker for assessing preclinical and clinical atherosclerosis in the general and high-risk populations [7, 24] . A strong association is observed between carotid atherosclerosis lesions and cardiovascular diseases, including myocardial infarction and stroke [7-9, 11, 24] .
To our knowledge, this is the first prospective population-based study investigating the risk of ischemic stroke in relation to carotid artery atherosclerosis in normotensive subjects. In this cohort, the signs of carotid atherosclerosis were observed in 39.5%. We found that for each 1-SD increase (0.13 mm) in CIMT, the risk of stroke significantly increased by 43% (95% CI: 1-102%). This point estimate is compatible with the results from a recent meta-analysis based on 8 observational studies [7] , in which the age-and sex-adjusted overall estimates of the relative risk of incident stroke was 1.32 (1.27-1.38) per 1-SD in CIMT difference. In addition, the incidence of ischemic stroke revealed a positive correlation with the grades of carotid plaques.
A combined measurement (CIMT 6 0.81mm or/and presence of plaque) was also utilized in this study to assess the impact of carotid artery atherosclerosis on stroke 1 RR were adjusted for age, sex, smoking, systolic BP, fasting blood glucose and LDL/HDL cholesterol ratio. 2 Information on carotid plaques was unavailable in 64 subjects. 3 CAA was defined as CIMT ≥0.81 or/and presence of plaque. risk. We found that the presence of CAA in normotensive subjects was associated with a 3-fold increase in relative and absolute risks of ischemic stroke. This association was only marginally attenuated by other cardiovascular risk factors.
Although the presence of atherosclerotic lesions was shown to be an independent marker of ischemic stroke among normotensive subjects during a 10-year follow-up, the absolute risk of ischemic stroke was 2.6%. It should be emphasized that the majority of subjects with presence of carotid atherosclerosis remained event free, which may imply that carotid atherosclerotic lesion could be present in the asymptomatic stage for a long period. Thus, appropriate interventions through behavioral modification and clinical management in this silent stage may reverse or delay the harmful progression [25] [26] [27] .
During the last decade, lipid-lowering therapy has been proved to be effective in reversing the progression of carotid atherosclerosis [25] [26] [27] . Lifestyle modification, lipid-and BP-lowering therapies have been proven to be effective in slowing the progression of CIMT [25] [26] [27] . However, the greater benefits have been shown when combing the interventions [26] .
Some methodological issues need to be addressed. In recent years, the measurements of the carotid plaque area are considered to be a stronger predictor of cardiovascular outcomes than CIMT [28, 29] . In this study, however, it was impossible to obtain information about the carotid plaque areas, since the present investigation was carried out in the early years of last decade. Lack of follow-up in carotid artery measurement and biological examinations is a limitation of this study. It is possible that carotid atherosclerosis may tend to deteriorate, and the prevalence of hypertension and lipid disturbances may increase during the years of follow-up since those conditions are age related [30] . The results might also be affected by chang- es in subjects' exposure to cardiovascular risk factors or medical interventions during follow-up.
The cutoff point for CIMT used in this study for presence of carotid atherosclerosis might also be questioned as the CIMT level might be influenced by the method of ultrasound measurements and age, sex, ethnic group, etc. [30] [31] [32] . However, CIMT was also a risk factor for ischemic stroke when it was used as a continuous variable. There is today no overall consensus about how to standardize the measurement of CIMT and the definition of presence of carotid plaques [33, 34] . It was recommended recently by the Mannheim CIMT Consensus that CIMT measurements should be taken in areas free of lesions and that 'plaque should be defined as a focal structure that encroaches into the arterial lumen of at least 0.5 mm or 50% of the surrounding intima-media thickness value or demonstrates a thickness 1 1.5 mm as measured from media-adventitia interface to intima-lumen interface' [33] . According to the recommended definition, which has been questioned [34] , the prevalence of carotid atherosclerosis in this cohort may be overestimated. However, our definition of CAA seems to be appropriate for the purpose of studying cardiovascular risk.
Summary
Carotid IMT and atherosclerotic lesions are independent clinical markers for ischemic stroke in subjects with normal blood pressure. Noninvasive assessment of carotid atherosclerosis seems to be a feasible method for tracking the progression of early stages of atherosclerotic disease, even in normotensives.
